Total Funding
4
Total FundingPost-IPO Equity raised
Growth Score in past quarter
pts
Heat Score 4 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
CellSeed is a biotechnology company that produces a number of cell sheet regenerative medicine products, including cell culture equipment.
- Yukio Hasegawa: Owner
About the Company
CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment of
osteoarthritis
The company was founded in 2001 and is headquartered in Tokyo, Japan.

